RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results

Comment: EUROCARE-5, large blood cancer survival differences throughout Europe

Comment: New immunotherapy options for kidney cancer

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer

Everolimus for non-functional neuroendocrine tumours

EUROCARE-5 results show large variations in survival from blood cancers between European countries

Nivolumab improves overall survival for advanced kidney cancer

METEOR trial results: Cabozantinib improves advanced kidney cancer survival

Atrial fibrillation in CLL patients on ibrutinib

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL